Nazal is a Nasal Liquid in the Human Otc Drug category. It is labeled and distributed by Sato Pharmaceutical Co., Ltd.. The primary component is Naphazoline Hydrochloride.
| Product ID | 49873-057_7750c714-3e28-4951-a0ea-b8521d6ec2a0 |
| NDC | 49873-057 |
| Product Type | Human Otc Drug |
| Proprietary Name | Nazal |
| Generic Name | Naphazoline Hydrochloride |
| Dosage Form | Liquid |
| Route of Administration | NASAL |
| Marketing Start Date | 1990-06-11 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part341 |
| Labeler Name | Sato Pharmaceutical Co., Ltd. |
| Substance Name | NAPHAZOLINE HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/100mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 1990-06-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 1990-06-11 |
| Ingredient | Strength |
|---|---|
| NAPHAZOLINE HYDROCHLORIDE | 50 mg/100mL |
| SPL SET ID: | 4d4043f8-5ed3-4027-beb6-687db1308202 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49873-057 | Nazal | Naphazoline hydrochloride |
| 21695-915 | AK-Con | naphazoline hydrochloride |
| 16995-001 | FLORIL REDNESS RELIEF | NAPHAZOLINE HYDROCHLORIDE |
| 48462-001 | NAFASOLINA | NAPHAZOLINE HYDROCHLORIDE |
| 63187-412 | Naphazoline | Naphazoline Hydrochloride |
| 51367-008 | Pi Yen Chin | Naphazoline Hydrochloride |
| 51367-035 | Pi Yen Chin | Naphazoline Hydrochloride |
| 63736-662 | Privine | Naphazoline Hydrochloride |
| 63736-663 | Privine | Naphazoline Hydrochloride |
| 49873-044 | Sato Clear | NAPHAZOLINE HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NAZAL 73380119 not registered Dead/Abandoned |
SATO PHARMACEUTICAL CO., LTD. 1982-08-16 |